BFRI - Biofrontera Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.78 -0.03 (-3.91%) --- --- --- --- -0.03 (-3.91%) --- ---

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.47
Diluted EPS:
-0.47
Basic P/E:
-1.5947
Diluted P/E:
-1.5947
RSI(14) 1m:
53.54
VWAP:
0.75
RVol:

Events

Period Kind Movement Occurred At

Related News